- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Serum GFAP as a biomarker for disease severity in multiple sclerosis ; volume:8 ; number:1 ; day:4 ; month:10 ; year:2018 ; pages:1-7 ; date:12.2018
Scientific reports ; 8, Heft 1 (4.10.2018), 1-7, 12.2018
- Creator
- Contributor
- DOI
-
10.1038/s41598-018-33158-8
- URN
-
urn:nbn:de:101:1-2018110810372779692299
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Abdelhak, Ahmed
- Huss, A.
- Kassubek, J.
- Tumani, H.
- Otto, Markus
- SpringerLink (Online service)
Other Objects (12)
Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis
Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity
Glial activation markers in CSF and serum from patients with primary progressive multiple sclerosis: potential of serum GFAP as disease severity marker?
Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
Correction: Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
Serum GFAP zur Schlaganfalldiagnostik in Regionen mit eingeschränkter Verfügbarkeit der kranialen Bildgebung
Serum vascular endothelial growth factor is a biomolecular biomarker of severity of diabetic retinopathy
Nachweis von saurem glialen Faserprotein (GFAP) in humanem Serum und erste klinische Ergebnisse
Complement C3 serum levels in anorexia nervosa: a potential biomarker for the severity of disease?
Plasma GFAP as a prognostic biomarker of motor subtype in early Parkinson’s disease
Das Gliafaserprotein (GFAP) in Hirntumoren
Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis
Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity
Glial activation markers in CSF and serum from patients with primary progressive multiple sclerosis: potential of serum GFAP as disease severity marker?
Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
Correction: Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
Serum GFAP zur Schlaganfalldiagnostik in Regionen mit eingeschränkter Verfügbarkeit der kranialen Bildgebung
Serum vascular endothelial growth factor is a biomolecular biomarker of severity of diabetic retinopathy
Nachweis von saurem glialen Faserprotein (GFAP) in humanem Serum und erste klinische Ergebnisse
Complement C3 serum levels in anorexia nervosa: a potential biomarker for the severity of disease?
Plasma GFAP as a prognostic biomarker of motor subtype in early Parkinson’s disease
Das Gliafaserprotein (GFAP) in Hirntumoren
Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis
Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity
Glial activation markers in CSF and serum from patients with primary progressive multiple sclerosis: potential of serum GFAP as disease severity marker?
Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
Correction: Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
Serum GFAP zur Schlaganfalldiagnostik in Regionen mit eingeschränkter Verfügbarkeit der kranialen Bildgebung
Serum vascular endothelial growth factor is a biomolecular biomarker of severity of diabetic retinopathy
Nachweis von saurem glialen Faserprotein (GFAP) in humanem Serum und erste klinische Ergebnisse
Complement C3 serum levels in anorexia nervosa: a potential biomarker for the severity of disease?
Plasma GFAP as a prognostic biomarker of motor subtype in early Parkinson’s disease